findmyKOL
Clinical trialNCT04453137CompletedPhase 3Interventional

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

SponsorAlvotech Swiss AGEnrollment567Plaque Psoriasis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Georgia
  • 9901

    Tbilisi, Georgia

  • Alvotech Swiss Ag - 9904

    Tbilisi, Georgia

  • Alvotech Swiss Ag - Site 9902

    Tbilisi, Georgia

  • Alvotech Swiss Ag - Site 9903

    Tbilisi, Georgia

Iceland
  • Alvotech Swiss Ag - Site 3501

    Reykjavik, Iceland

Poland
  • Alvotech Swiss Ag - Site 4803

    Gdansk, Poland

  • Alvotech Swiss Ag - Site 4804

    Krakow, Poland

  • Alvotech Swiss Ag - Site 4807

    Krakow, Poland

  • Alvotech Swiss Ag - Site 4805

    Lodz, Poland

  • Alvotech Swiss Ag - Site 4806

    Torun, Poland

  • Alvotech Swiss Ag - 4808

    Wroclaw, Poland

  • Wromedica Centrum Zdrowia

    Wroclaw, Poland

Russia
  • Alvotech Swiss Ag - Site 7001

    Kemerovo, Russia

  • Alvotech Swiss Ag - Site 7005

    Krasnodar, Russia

  • Alvotech Swiss Ag - Site 7003

    Saint Petersburg, Russia

  • Alvotech Swiss Ag - Site 7004

    Saint Petersburg, Russia

  • Alvotech Swiss Ag - Site 7006

    Saint Petersburg, Russia

  • Alvotech Swiss Ag - Site 7002

    Saratov, Russia

Ukraine
  • Alvotech Swiss Ag - Site 3805

    Kharkiv, Ukraine

  • Alvotech Swiss Ag - Site 3807

    Kharkiv, Ukraine

  • Alvotech Swiss Ag - Site 3801

    Kyiv, Ukraine

  • Alvotech Swiss Ag - Site 3806

    Kyiv, Ukraine

  • Alvotech Swiss Ag - Site 3802

    Rivne, Ukraine

  • Alvotech Swiss Ag - Site 3804

    Uzhhorod, Ukraine

  • Alvotech Swiss Ag - Site 3803

    Zaporizhzhya, Ukraine

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2020
Primary completion
31 May 2021
Completion
16 Nov 2021
Last update posted
4 May 2022
Registered enrollment
567
Registry id
NCT04453137
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.